Running News Daily is edited by Bob Anderson in Los Altos California USA and team in Thika Kenya, La Piedad Mexico, Bend Oregon, Chandler Arizona and Monforte da Beira Portugal. Send your news items to bob@mybestruns.com Advertising opportunities available. Train the Kenyan Way at KATA Kenya. (Kenyan Athletics Training Academy) in Thika Kenya. KATA Portugal at Anderson Manor Retreat in central portugal. Learn more about Bob Anderson, MBR publisher and KATA director/owner, take a look at A Long Run the movie covering Bob's 50 race challenge.
Index to Daily Posts · Sign Up For Updates · Run The World Feed
Dr. Michael Joyner of the Mayo Clinic is best known in running circles as being the guy who in 1991 published a paper saying a human being could run a marathon in 1:57:58. Joyner, an anesthesiologist and physiologist by trade, now is using his skills on a much more serious matter by helping lead the National COVID-19 Convalescent Plasma Project (CCPP19). The CCPP19 is a nationwide effort of researchers, institutions, and blood blanks to try to use plasma from recovered COVID-19 patients to better treat patients suffering from COVID-19.
“What we’re trying to do is leverage the antibodies produced by people who have recovered from COVID-19. Harvest those antibodies from recovered patients and then give these antibodies in the form of plasma to people to either prevent disease in people that have been exposed but aren’t yet sick, to treat people who are in the hospital and try to keep them from going to the intensive care unit, or to try to shorten the stay in the intensive care unit. This is called convalescent plasma therapy. It’s been around since the late 1800s. It’s worked numerous times before,” said Joyner on this week’s LetsRun.com Track Talk Podcast.
Joyner said the goal is for people to continue to practice social distancing and proper pandemic control while groups like his develop better short-term treatments for COVID-19 before a vaccine can be made to really stop the virus.
“We believe it’s our best shot on kind of [a] biological goal in the short run, and then after that, we anticipate concentrated gamma globulin, like antibodies, [being] available toward the end of the summer. And then we are waiting for the vaccine and biotech cavalry to come to the rescue,” Joyner said.
Running did play a tangential role in getting Joyner involved with CCPP19. Joyner has always been interested in oxygen transport and physiology because of his days as a competitive runner at the University of Arizona. Recently, Joyner was on Twitter and he saw a retweet by David Epstein, the former Columbia 800m runner and former ProPublica journalist who, along with the BBC, broke the allegations that Alberto Salazar and the Nike Oregon Project were breaking anti-doping rules.
The retweet was a link to a Wall Street Journal article by Dr. Arturo Casadevall on using antibodies to try to treat the coronavirus:
(04/12/2020) Views: 1,508 ⚡AMP